Literature DB >> 1390689

Inhibition of protein kinase C by cationic amphiphiles.

R Bottega1, R M Epand.   

Abstract

A large number of PKC inhibitors are positively charged. We evaluated the structural features of cationic amphiphiles which are necessary for inhibiting PKC. Many of these compounds were derivatives of cholesterol, which possesses a hydrophobic backbone which does not perturb hydrocarbon packing in membrane bilayers. In addition, they contain a tertiary or quaternary nitrogen functionality in the head group. All designed cholesterol-based amphiphiles inhibit PKC activity; the potency of the amphiphile correlates with the presence of positive charge. Quaternary ammonium amphiphiles are 10-fold more potent than their tertiary amine counterparts, generally inhibiting in the 10-60 microM range using the Triton mixed micelle assay. Aside from charge, factors such as the structure of the amine-containing head group, its length from the hydrocarbon moiety, or the number of amine groups on the amphiphile did not markedly influence inhibitor potency. In contrast, the hydrocarbon backbone did influence potency: cationic amphiphiles containing a steroid backbone were more potent inhibitors of PKC than their straight-chain analogues. Changing the nature of the hydrocarbon from a sterol to an alkyl group lowers the pK of the amine head group so that the straight-chain analogues are no longer cationic in the conditions in the PKC assay. The results of these studies suggest that a combination of positive charge and a bilayer-stabilizing structural characteristic provides a basis for the rational design of PKC inhibitors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390689     DOI: 10.1021/bi00152a045

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

Review 1.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 2.  Delivery materials for siRNA therapeutics.

Authors:  Rosemary Kanasty; Joseph Robert Dorkin; Arturo Vegas; Daniel Anderson
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

3.  Synthesis and characterization of a series of carbamate-linked cationic lipids for gene delivery.

Authors:  Dongliang Liu; Jianjun Hu; Weihong Qiao; Zongshi Li; Shubiao Zhan; Lvbo Cheng
Journal:  Lipids       Date:  2005-08       Impact factor: 1.880

Review 4.  Transfection by cationic gemini lipids and surfactants.

Authors:  M Damen; A J J Groenen; S F M van Dongen; R J M Nolte; B J Scholte; M C Feiters
Journal:  Medchemcomm       Date:  2018-07-17       Impact factor: 3.597

5.  Novel gemini cationic lipids with carbamate groups for gene delivery.

Authors:  Yi-Nan Zhao; Farooq Qureshi; Shu-Biao Zhang; Shao-Hui Cui; Bing Wang; Hui-Ying Chen; Hong-Tao Lv; Shu-Fen Zhang; Leaf Huang
Journal:  J Mater Chem B       Date:  2014-05-21       Impact factor: 6.331

6.  Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.

Authors:  Bo Xiao; Hamed Laroui; Emilie Viennois; Saravanan Ayyadurai; Moiz A Charania; Yuchen Zhang; Zhan Zhang; Mark T Baker; Benyue Zhang; Andrew T Gewirtz; Didier Merlin
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

7.  Critical role of diacylglycerol- and phospholipid-regulated protein kinase C epsilon in induction of low-density lipoprotein receptor transcription in response to depletion of cholesterol.

Authors:  Kamal D Mehta; Anna Radominska-Pandya; Gurpreet S Kapoor; Bhuvanesh Dave; Brett A Atkins
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

8.  Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy.

Authors:  Bo Xiao; Hamed Laroui; Saravanan Ayyadurai; Emilie Viennois; Moiz A Charania; Yuchen Zhang; Didier Merlin
Journal:  Biomaterials       Date:  2013-06-29       Impact factor: 12.479

Review 9.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

10.  Overcoming nonviral gene delivery barriers: perspective and future.

Authors:  Charles H Jones; Chih-Kuang Chen; Anitha Ravikrishnan; Snehal Rane; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-16       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.